St. Jude Medical to acquire wireless pacemaker co Nanostim, DJ reports St. Jude Medical is planning to acquire wireless pacemaker manufacturer Nanostim, according to a Dow Jones report that cites comments made by St. Jude CEO Dan Starks at the company's investor meeting Friday. The report says financial terms of the deal were not disclosed. Reference Link
Leerink medical devices analyst holds an analyst/industry conference call Medical Devices Analyst Antalffy discusses the ultimate market opportunity for leadless pacers and compares Medtronic vs St. Jude Medical on an Analyst/Industry conference call to be held on September 24 at 2 pm.
St. Jude Medical recent weakness a buying opportunity, says Barclays Barclays said St. Jude Medical weakness is a buying opportunity. The analyst said CardioMEMS is underappreciated by the Street and valuation compelling given sequential revenue growth. Shares are Overweight rated.